Transposition from a gutless adeno-transposon vector stabilizes transgene expression in vivo

Nature Biotechnology

Volumn 20, Issue 10, 2002, Pages 999-1005

  Yant, Stephen R ^a   Ehrhardt, Anja ^a   Mikkelsen, Jacob Giehm ^a   Meuse, Leonard ^a   Pham, Thao ^a   Kay, Mark A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOMES; DISEASES; DNA; DRUG THERAPY; VECTORS;

GENE THERAPY;

GENETIC ENGINEERING;

VIRUS VECTOR;

ADENOVIRUS; ARTICLE; CELL PROLIFERATION; CHROMOSOME; CONTROLLED STUDY; DNA TRANSPOSITION; DNA VECTOR; EUKARYOTE; GENE DELETION; GENE THERAPY; GENETIC DISORDER; GENOME; HOST CELL; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; TRANSGENE; TRANSPOSON;

ADENOVIRIDAE; ANIMALS; DNA TRANSPOSABLE ELEMENTS; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; HELA CELLS; HUMANS; LIVER; MICE; MICE, INBRED C57BL; TRANSGENES; TRANSPOSASES;

ADENOVIRIDAE; DNA VIRUSES; EUKARYOTA; TRANSPOSONS;

EID: 0036789403     PISSN: 10870156     EISSN: None     Source Type: Journal    
DOI: 10.1038/nbt738     Document Type: Article

References (49)

1. Kozarsky, K.F. & Wilson, J.M. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 3, 499-503 (1993).
2. Yang, Y. et al. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411 (1994).
3. Yang, Y., Li, Q., Ertl, H.C. & Wilson, J.M. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses. J. Virol. 69, 2004-2015 (1995).
4. Yang, Y., Jooss, K.U., Su, Q., Ertl, H.C. & Wilson, J.M. Immune responses to viral antigens versus transgene product in the elimination of recombinant adenovirus-infected hepatocytes in vivo. Gene Ther. 3, 137-144 (1996).
5. Parks, R.J. et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc. Natl. Acad. Sci. USA 93, 13565-13570 (1996).
6. Schiedner, G. et al. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18, 180-183 (1998).
7. Balague, C. et al. Sustained high-level expression of full-length human Factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood 95, 820-828 (2000).
8. Clemens, P.R. et al. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes. Gene Ther. 3, 965-972 (1996).
9. Morral, N. et al. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of α1-antitrypsin with negligible toxicity. Hum. Gene Ther. 9, 2709-2716 (1998).
10. Morral, N. et al. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl. Acad. Sci. USA 96, 12816-12821 (1999).
11. Ehrhardt, A. & Kay, M.A. A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation Factor IX at low doses in vivo. Blood 99, 1-8 (2002).
12. Kim, I.H., Jozkowicz, A., Piedra, P.A., Oka, K. & Chan, L. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc. Natl. Acad. Sci. USA 98, 13282-13287 (2001).
13. Harui, A., Suzuki, S., Kochanek, S. & Mitani, K. Frequency and stability of chromosomal integration of adenovirus vectors. J. Virol. 73, 6141-6146 (1999).
14. Hillgenberg, M., Tonnies, H. & Strauss, M. Chromosomal integration pattern of a helper-dependent minimal adenovirus vector with a selectable marker inserted into a 27.4-kilobase genomic stuffer. J. Virol. 75, 9896-9908 (2001).
15. Plasterk, R.H., Izsvak, Z. & Ivics, Z. Resident aliens: the Tc 1/mariner superfamily of transposable elements. Trends Genet. 15, 326-332 (1999).
16. Fischer, S.E., Wienholds, E. & Plasterk, R.H. Regulated transposition of a fish transposon in the mouse germ line. Proc. Natl. Acad. Sci. USA 98, 6759-6764 (2001).
17. Ivics, Z., Hackett, P.B., Plasterk, R.H. & Izsvak, Z. Molecular reconstruction of Sleeping Beauty, a Tc1-like transposon from fish, and its transposition in human cells. Cell 191, 501-510 (1997).
18. Yant, S.R. et al. Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat. Genet. 25, 35-41 (2000).
19. Nakai, H. et al. Extrachromosomal recombinant adeno-associated virus vector genomes are primarily responsible for stable liver transduction in vivo. J. Virol. 75, 6969-6976 (2001).
20. Vos, J.C., De Baere, I. & Plasterk, R.H. Transposase is the only nematode protein required for in vitro transposition of Tc1. Genes Dev. 10, 755-761 (1996).
21. Ng, P., Beauchamp, C., Evelegh, C., Parks, R. & Graham, F.L. Development of a FLP/frt system for generating helper-dependent adenoviral vectors. Mol. Ther. 3, 809-815 (2001).
22. Rodriguez, C.I. et al. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat. Genet. 25, 139-140 (2000).
23. Plasterk, R.H. The Tc 1/mariner transposon family. Curr. Top. Microbiol. Immunol. 204, 125-143 (1996).
24. Miller, D.G., Rutledge, E.A. & Russell, D.W. Chromosomal effects of adeno-associated virus vector integration. Nat. Genet. 30, 147-148 (2002).
25. Nakai, H., Iwaki, Y., Kay, M.A. & Couto, L.B. Isolation of recombinant adeno-associated virus vector-cellular DNA junctions from mouse liver. J. Virol. 73, 5438-5447 (1999).
26. Chalmers, R., Guhathakurta, A., Benjamin, H. & Kleckner, N. IHF modulation of Tn10 transposition: sensory transduction of supercoiling status via a proposed protein/DNA molecular spring. Cell 93, 897-908 (1998).
27. Crellin, P. & Chalmers, R. Protein-DNA contacts and conformational changes in the Tn10 transpososome during assembly and activation for cleavage. EMBO J. 20, 3882-3891 (2001).
28. Wang, Z. & Harshey, R.M. Crucial role for DNA supercoiling in Mu transposition: a kinetic study. Proc. Natl. Acad. Sci. USA 91, 699-703 (1994).
29. Soifer, H. et al. Stable integration of transgenes delivered by a retrotransposon-adenovirus hybrid vector. Hum. Gene Ther. 12, 1417-1428 (2001).
30. Lieber, A., Steinwaerder, D.S., Carlson, C.A. & Kay, M.A. Integrating adenovirusadeno-associated virus hybrid vectors devoid of all viral genes. J. Virol. 73, 9314-9324 (1999).
31. Recchia, A. et al. Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proc. Natl. Acad. Sci. USA 96, 2615-2620 (1999).
32. Zheng, C., Baum, B.J., Iadarola, M.J. & O'Connell, B.C. Genomic integration and gene expression by a modified adenoviral vector. Nat. Biotechnol. 18, 176-180 (2000).
33. Murphy, S.J., Chong, H., Bell, S., Diaz, R.M. & Vile, R.G. Novel integrating adenoviral/retroviral hybrid vector for gene therapy. Hum. Gene Ther. 13, 745-760 (2002).
34. Soifer, H. et al. A novel, helper-dependent, adenovirus-retrovirus hybrid vector: stable transduction by a two-stage mechanism. Mol. Ther. 5, 599-608 (2002).
35. Shayakhmetov, D.M. et al. A high-capacity, capsid-modified hybrid adenovirus/adeno-associated virus vector for stable transduction of human hematopoietic cells. J. Virol. 76, 1135-1143 (2002).
36. Feng, M. et al. Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector. Nat. Biotechnol. 15, 866-870 (1997).
37. Luo, G., Ivics, Z., Izsvak, Z. & Bradley, A. Chromosomal transposition of a Tc1/mariner-like element in mouse embryonic stem cells. Proc. Natl. Acad. Sci. USA 95, 10769-10773 (1998).
38. Peters, A.H. et al. Absence of germline infection in male mice following intraventricular injection of adenovirus. Mol. Ther. 4, 603-613 (2001).
39. Kanatsu-Shinohara, M. et al. Adenovirus-mediated gene delivery and in vitro microinsemination produce offspring from infertile male mice. Proc. Natl. Acad. Sci. USA 99, 1383-1388 (2002).
40. Tallone, T. et al. A mouse model for adenovirus gene delivery. Proc. Natl. Acad. Sci. USA 98, 7910-7915 (2001).
41. Steinwaerder, D.S. & Lieber, A. Insulation from viral transcriptional regulatory elements improves inducible transgene expression from adenovirus vectors in vitro and in vivo. Gene Ther. 7, 556-567 (2000).
42. Groth, A.C., Olivares, E.C., Thyagarajan, B. & Calos, M.P. A phage integrase directs efficient site-specific integration in human cells. Proc. Natl. Acad. Sci. USA 97, 5995-6000 (2000).
43. Thyagarajan, B., Olivares, E.C., Hollis, R.P., Ginsburg, D.S. & Calos, M.P. Site-specific genomic integration in mammalian cells mediated by phage phiC31 integrase. Mol. Cell. Biol. 21, 3926-3934 (2001).
44. Burr, A.W., Carpenter, M.R., Hines, J.E., Gullick, W.J. & Burt, A.D. Intrahepatic distribution of transforming growth factor-α (TGFα) during liver regeneration following carbon tetrachloride-induced necrosis. J. Pathol. 170, 95-100 (1993).
45. Liu, F., Song, Y. & Liu, D. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Ther. 6, 1258-1266 (1999).
46. Zhang, G:, Budker, V. & Wolff, J.A. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum. Gene Ther. 10, 1735-1737 (1999).
47. McGrory, W.J., Bautista, D.S. & Graham, F.L. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology 163, 614-617 (1988).
48. Kay, M.A., Graham, F., Leland, F. & Woo, S.L. Therapeutic serum concentrations of human α1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes. Hepatology 21, 815-819 (1995).
49. Izsvak, Z., Ivics, Z. & Plasterk, R.H. Sleeping Beauty, a wide host-range transposon vector for genetic transformation in vertebrates. J. Mol. Biol. 302, 93-102 (2000).